Reporting Owner Activity for Andy Sassine

Form 3/4/5 issuer positions and transaction evidence for this reporting owner.

Issuer positions

3

Largest position

Arcturus Therapeutics Holdings Inc.

Disclosed value

$3.67M

Recent activity

Available

Identity
Location
Boston, MA
SEC ownership signals
Ownership summary

Disclosed holdings value

$3,671,968

Estimated from parsed Forms 3/4/5 holdings when values are available.

Issuer positions

3

Distinct issuers linked to this reporting owner in parsed SEC filings.

Largest parsed position

Arcturus Therapeutics Holdings Inc. (ARCT)

About $3.67M reported in parsed filings.

Latest ownership filing

20 Aug 2025

Most recent owner-level filing date in the parsed SEC record.

+2 more

Additional issuer positions are listed below.

Values come from parsed SEC Forms 3/4/5 and should be verified against the source filing.

SEC record
Reporting signature
/s/ Ilan Katz, attorney-in-fact
SEC evidence

Follow Filing Activity

Follow Andy Sassine and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Reported issuer positions for Andy Sassine

ICAD Forms 3/4/5

ICAD INC

Relationship
Director
Holdings value
$0
Past year net change
Change %
Report period
17 Jul 2025
XCUR Forms 3/4/5

EXICURE, INC.

Relationship
Director
Holdings value
Past year net change
Change %
Report period
02 Jun 2021

Insider Transactions Reported by Andy Sassine:

Sym Company Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .